{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:32:40Z","timestamp":1791329560078,"version":"4.3.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":4185,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1194\/jlr.r800088-jlr200","type":"journal-article","created":{"date-parts":[[2008,12,8]],"date-time":"2008-12-08T21:08:41Z","timestamp":1228770521000},"page":"S189-S194","source":"Crossref","is-referenced-by-count":520,"special_numbering":"S","title":["The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis"],"prefix":"10.1016","volume":"50","author":[{"given":"Daniel J.","family":"Rader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginny L.","family":"Weibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Billheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George H.","family":"Rothblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.R800088-JLR200_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithin:cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R800088-JLR200_bib2","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI30163","article-title":"Molecular regulation of HDL metabolism and function: implications for novel therapies","volume":"116","author":"Rader","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800088-JLR200_bib3","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1073\/pnas.092327399","article-title":"Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues","volume":"99","author":"Van Eck","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R800088-JLR200_bib4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.ATV.0000208364.22732.16","article-title":"Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice","volume":"26","author":"Van Eck","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib5","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800088-JLR200_bib6","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R800088-JLR200_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cmet.2005.01.002","article-title":"ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation","volume":"1","author":"Kennedy","year":"2005","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.R800088-JLR200_bib8","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/01.ATV.0000240051.22944.dc","article-title":"Impaired development of atherosclerosis in hyperlipidemic Ldlr\u2212\/\u2212 and ApoE\u2212\/\u2212 mice transplanted with Abcg1\u2212\/\u2212 bone marrow","volume":"26","author":"Baldan","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib9","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/01.ATV.0000242275.92915.43","article-title":"Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1\u2212\/\u2212 bone marrow","volume":"26","author":"Ranalletta","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.0000200082.58536.e1","article-title":"ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I","volume":"26","author":"Gelissen","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib11","first-page":"3900","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Yvan-Charvet","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800088-JLR200_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/CIRCULATIONAHA.105.560177","article-title":"Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo","volume":"113","author":"Naik","year":"2006","journal-title":"Circulation."},{"key":"10.1194\/jlr.R800088-JLR200_bib13","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R800088-JLR200_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.ATV.0000150044.84012.68","article-title":"Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists","volume":"25","author":"Levin","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis","volume":"7","author":"Chawla","year":"2001","journal-title":"Mol. Cell."},{"key":"10.1194\/jlr.R800088-JLR200_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","article-title":"PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway","volume":"7","author":"Chinetti","year":"2001","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.R800088-JLR200_bib17","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1172\/JCI18730","article-title":"Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta\/delta, and gamma","volume":"114","author":"Li","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800088-JLR200_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-2275(20)32113-1","article-title":"Cell cholesterol efflux: integration of old and new observations provides new insights","volume":"40","author":"Rothblat","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R800088-JLR200_bib19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/01.ATV.0000083343.19940.A0","article-title":"Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells","volume":"23","author":"Covey","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib20","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1161\/01.CIR.0000093189.97429.9D","article-title":"Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation."},{"key":"10.1194\/jlr.R800088-JLR200_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1034\/j.1600-0463.2000.d01-65.x","article-title":"Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis","volume":"108","author":"Mehlum","year":"2000","journal-title":"APMIS."},{"key":"10.1194\/jlr.R800088-JLR200_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nm0797-744","article-title":"High plasma HDL concentration associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase","volume":"3","author":"Berard","year":"1997","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.R800088-JLR200_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.108.825109","article-title":"LCAT expression has minimal effects on macrophage reverse cholesterol transport in vivo","author":"Tanigawa","year":"2009","journal-title":"Circulation"},{"key":"10.1194\/jlr.R800088-JLR200_bib24","doi-asserted-by":"crossref","first-page":"36912","DOI":"10.1074\/jbc.274.52.36912","article-title":"Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice","volume":"274","author":"Foger","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R800088-JLR200_bib25","doi-asserted-by":"crossref","first-page":"11448","DOI":"10.1073\/pnas.93.21.11448","article-title":"Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis","volume":"93","author":"Hoeg","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R800088-JLR200_bib26","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.1074\/jbc.M008466200","article-title":"Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice","volume":"276","author":"Lambert","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R800088-JLR200_bib27","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1074\/jbc.M109883200","article-title":"Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice","volume":"277","author":"Furbee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R800088-JLR200_bib28","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1194\/jlr.M300511-JLR200","article-title":"Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans","volume":"45","author":"Schwartz","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R800088-JLR200_bib29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.ATV.20.3.721","article-title":"Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse","volume":"20","author":"Kozarsky","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib30","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1074\/jbc.274.4.2366","article-title":"Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene","volume":"274","author":"Arai","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R800088-JLR200_bib31","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1172\/JCI25327","article-title":"Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo","volume":"115","author":"Zhang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800088-JLR200_bib32","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/CIRCULATIONAHA.107.704254","article-title":"Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport","volume":"116","author":"Tanigawa","year":"2007","journal-title":"Circulation."},{"key":"10.1194\/jlr.R800088-JLR200_bib33","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMe0707210","article-title":"Illuminating HDL\u2013is it still a viable therapeutic target?","volume":"357","author":"Rader","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R800088-JLR200_bib34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.ATV.0000161928.16334.dd","article-title":"Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion","volume":"25","author":"Brousseau","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib35","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1172\/JCI27602","article-title":"HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway","volume":"116","author":"Matsuura","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800088-JLR200_bib36","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.106.138347","article-title":"Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL","volume":"27","author":"Yvan-Charvet","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11883-004-0052-3","article-title":"Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein","volume":"6","author":"Rader","year":"2004","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1194\/jlr.R800088-JLR200_bib38","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R800088-JLR200_bib39","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/ATVBAHA.108.165803","article-title":"Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages","volume":"28","author":"Sehayek","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R800088-JLR200_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/07853890310020635","article-title":"The ins and outs of reverse cholesterol transport","volume":"36","author":"Groen","year":"2004","journal-title":"Ann. Med."},{"key":"10.1194\/jlr.R800088-JLR200_bib41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.CIR.0000086981.09834.E0","article-title":"Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation."},{"key":"10.1194\/jlr.R800088-JLR200_bib42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.RES.0000185320.82962.F7","article-title":"Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation","volume":"97","author":"Moore","year":"2005","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.R800088-JLR200_bib43","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.100.6.594","article-title":"Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I: potential reverse cholesterol transport in humans","volume":"100","author":"Eriksson","year":"1999","journal-title":"Circulation."},{"key":"10.1194\/jlr.R800088-JLR200_bib44","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2008.03.016","article-title":"Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches","volume":"51","author":"deGoma","year":"2008","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520306106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520306106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.R800088-JLR200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T10:12:34Z","timestamp":1637403154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520306106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":44,"alternative-id":["S0022227520306106"],"URL":"https:\/\/doi.org\/10.1194\/jlr.r800088-jlr200","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}